- Home
- SCWO vs CRBP Comparison
SCWO vs CRBP Comparison
Compare SCWO & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCWO
- CRBP
- Stock Information
- Founded
- SCWO 2021
- CRBP 2009
- Country
- SCWO United States
- CRBP United States
- Employees
- SCWO N/A
- CRBP N/A
- Industry
- SCWO Environmental Services
- CRBP Biotechnology: Pharmaceutical Preparations
- Sector
- SCWO Utilities
- CRBP Health Care
- Exchange
- SCWO Nasdaq
- CRBP Nasdaq
- Market Cap
- SCWO 64.3M
- CRBP 73.4M
- IPO Year
- SCWO N/A
- CRBP N/A
- Fundamental
- Price
- SCWO $0.26
- CRBP $6.09
- Analyst Decision
- SCWO
- CRBP Strong Buy
- Analyst Count
- SCWO 0
- CRBP 10
- Target Price
- SCWO N/A
- CRBP $60.89
- AVG Volume (30 Days)
- SCWO 287.4K
- CRBP 203.7K
- Earning Date
- SCWO 05-14-2025
- CRBP 05-06-2025
- Dividend Yield
- SCWO N/A
- CRBP N/A
- EPS Growth
- SCWO N/A
- CRBP N/A
- EPS
- SCWO N/A
- CRBP N/A
- Revenue
- SCWO $445,445.00
- CRBP N/A
- Revenue This Year
- SCWO $5,945.19
- CRBP N/A
- Revenue Next Year
- SCWO $106.82
- CRBP $150.00
- P/E Ratio
- SCWO N/A
- CRBP N/A
- Revenue Growth
- SCWO N/A
- CRBP N/A
- 52 Week Low
- SCWO $0.25
- CRBP $4.64
- 52 Week High
- SCWO $1.99
- CRBP $61.90
- Technical
- Relative Strength Index (RSI)
- SCWO 39.97
- CRBP 47.64
- Support Level
- SCWO $0.33
- CRBP $5.68
- Resistance Level
- SCWO $0.30
- CRBP $6.03
- Average True Range (ATR)
- SCWO 0.03
- CRBP 0.44
- MACD
- SCWO -0.00
- CRBP 0.18
- Stochastic Oscillator
- SCWO 14.33
- CRBP 79.39
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.